Novel Agent Shows Potential for Advanced Lung CancerNovel Agent Shows Potential for Advanced Lung Cancer

A novel heat shock protein inhibitor that acts as a molecular 'chaperone' showed promising activity when added to docetaxel in advanced lung cancer. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news